Optimizing Treatment of Neisseria gonorrhoeae, Appendix 1 | CDC EID

Skip Standard Navigation Links

Past Issue

Vol. 11, No. 8
August 2005

EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript


•	Appendix 1 Figure 1
•	Appendix 1 Figure 2
•	Appendix 1 Figure 3
•	Appendix 1 Figure 4
•	Appendix 2
•	Appendix 3
•	Back to article

Research

Optimizing Treatment of Antimicrobial-resistant Neisseria gonorrhoeae

Kakoli Roy,* Susan A. Wang,* and Martin I. Meltzer*
*Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Appendix 1. Decision Trees

Following are links to schematic diagrams showing the decision trees used to produce the results presented in this article.

Appendix 1 Figure 1. The 4 strategies; + denotes "truncated" branch; GC, gonorrhea.

Appendix 1 Figure 2. Cost of gonorrhea transmission.

Appendix 1 Figure 3. Cost of HIV transmission. GC, gonorrhea.

Appendix 1 Figure 4. Weighted cost of treating gonorrhea infection and sequelae in 2001 US dollars.

Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Kakoli Roy, Office of Workforce and Career Development, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop E90, Atlanta, GA 30333, USA; fax: 404-498-6145; email: kjr3@cdc.gov

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Comments to the EID Editors

Please contact the EID Editors at eideditor@cdc.gov

		EID Home \| Top of Page \| Ahead-of-Print \| Past Issues \| Suggested Citation \| EID Search \| Contact Us \| Accessibility \| Privacy Policy Notice \| CDC Home \| CDC Search \| Health Topics A-Z

		This page posted July 14, 2005 This page last reviewed July 13, 2005

		Emerging Infectious Diseases Journal National Center for Infectious Diseases Centers for Disease Control and Prevention